BETANSEBeta Drugs Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 6 Nov, 2025 · 15:10 IST

Beta Drugs H1 FY26: revenue up 13%, EBITDA up 17%

Ebitda Margin ExpansionExceptional ItemResults View source PDFExplain this filing

BETA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.4%Reaction day
₹1735.00
prior close
₹1764.90
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.7%+0.3% vs market
Pharmaceuticals peers, median of 156sector-1.1%-0.3% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.3
10m
-1.4
15m
-1.4
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.4-1.7+0.3-1.1-0.3
Next day
-2.3-1.3-1.0-1.4-1.0
2d
-2.6-1.7-0.9-2.0-0.6
3d
-3.2-1.9-1.2-2.3-0.9
4d
-3.4-1.0-2.4-1.2-2.2
5d
-3.2-1.1-2.1-1.5-1.7
1w
-4.8-0.6-4.2-1.7-3.2
15d
-4.9-3.0-1.9-4.3-0.6
1m
-6.1-8.1+2.0-7.0+0.9
2m
-4.0-4.8+0.8-5.2+1.2
3m
-20.2-9.1-11.1-8.9-11.4
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

H1 FY26 consolidated revenue rose 13% to Rs 203.6 crore and EBITDA rose 17% to Rs 47 crore. Margin improved to 23.08% from 22.36%. Profit after tax excluding debenture interest rose 18% to Rs 28.71 crore; reported profit was nearly flat at Rs 23.95 crore. A Rs 4.56 crore preference-share issue item was exceptional. Flood damage caused a two-week plant shutdown. The review found no material misstatement. FY26 revenue target: Rs 420-430 crore.

Likely market impact

Likely positive: revenue, EBITDA, adjusted profit and margins rose. Flood recovery and exports may help, though plant disruption remains a risk.